Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Amphastar’s $1.075 Billion Acquisition of BAQSIMI from Eli Lilly
Wilson, Sonsini is acting as legal counsel to Amphastar. Kirkland & Ellis and Covington & Burling are acting as legal counsel to Lilly. In an effort...
Third Rock Ventures’ Investment in CARGO Therapeutics
Orrick advised Third Rock Ventures on the deal while Wilson Sonsini represented CARGO Therapeutics. Third Rock Ventures announced its investment in the $200 million Series A financing...
Arcellx’s $4 Billion Collaboration with Kite
Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction. Clinical-stage biotechnology company Arcellx and Gilead-owned biopharmaceutical company Kite announced a global strategic collaboration to develop...
Apexigen’s Business Combination Agreement with Brookline Capital Acquisition Corp.
Wilson Sonsini advised Apexigen on the deal. Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology,...
Crinetics’ Launch of Radionetics Oncology
Wilson Sonsini Goodrich & Rosati advised Crinetics on the deal. Crinetics Pharmaceuticals, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel...